Literature DB >> 15007139

TNF-376A marks susceptibility to MS in the Spanish population: A replication study.

A Martínez1, A Rubio, E Urcelay, M Fernández-Arquero, V De Las Heras, R Arroyo, P Villoslada, X Montalbán, E G De La Concha.   

Abstract

This study was designed as a reappraisal of the association between the TNF-376A promoter polymorphism and susceptibility to multiple sclerosis found in the Spanish population but not in other populations. With a new dataset of patients (n = 241) and control subjects (n = 288), the association was confirmed (p = 0.018). The authors' data suggest that this association is specific of the Spanish white (or related) population or, alternatively, that only studies in their population have the adequate statistical power because of the higher frequency of an extended, conserved haplotype carrying the TNF-376A allele.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007139     DOI: 10.1212/01.wnl.0000113722.93895.8b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Tumor necrosis factor alpha gene -376 polymorphism and susceptibility to multiple sclerosis: an Egyptian study.

Authors:  Mona Abd el Fattah Nada; Dalia Ahmed Labib
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-25       Impact factor: 4.147

3.  DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bands.

Authors:  Emilio G de la Concha; María L Cavanillas; M Carmen Cénit; Elena Urcelay; Rafael Arroyo; Óscar Fernández; José C Álvarez-Cermeño; Laura Leyva; Luisa M Villar; Concepción Núñez
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

4.  TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study.

Authors:  Elizabeth Córdoba-Lanús; Rebeca Baz-Dávila; Juan P de-Torres; María C Rodríguez-Pérez; Nicole Maca-Meyer; Nerea Varo; Chaxiraxi Medina-Coello; Armando Aguirre-Jaime; Ciro Casanova
Journal:  BMC Med Genet       Date:  2011-10-10       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.